PubCoCEO™

QBie™ Spotlight joins Brady Granier, President/CEO/Director of BioCorRx Inc. (OTCQB: BICX), to discuss one of the OTCQB’s newest additions. BICX joined the OTCQB on March 21, 2017.  

What does BioCorRx do?

Brady Granier (President/CEO/Director – OTCQB: BICX):  “We are an addiction treatment company offering a unique approach to the treatment of substance abuse addiction. The BioCorRx® Recovery Program, a non-addictive, medication-assisted treatment (MAT) program, consists of two main components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can significantly reduce physical cravings for alcohol and opioids. The second component of the program developed by BioCorRx Inc. is a one-on-one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. The Company also has an R&D subsidiary, BioCorRx Pharmaceuticals, which is currently developing a new injectable naltrexone technology (BICX101) through a partnership with TheraKine Ltd.”   

What is the next big goal BICX is trying to accomplish/what should we keep an eye out for? 

Brady Granier: “The company plans to seek FDA approval for BICX101 and/or its naltrexone implant product(s).“

Why did you join the OTCQB/go public?

Brady Granier: “Current management took over the company long after it went public via reverse merger in 2011. From inception, We have been a fully reporting company and feel that the OTCQB is a better place to be at this stage of our company. However, we have larger goals.”  

How can members of the microcap community help you?

Brady Granier: “By spreading the word of our great company and the good things we are doing and will continue to do to battle the current opioid crisis and massive alcohol use disorder problem. Tell everyone to just keep an eye on us.“

Learn more about BioCorRx Inc. (OTCQB: BICX) at: www.BioCorRx.com and www.BeatAddiction.com

Brady Granier, President/CEO/Director of BioCorRx, can be reached via email at: Brady@BioCorRx.com

About QBie™ Spotlight:

QBie™ Spotlight is a virtual “welcome interview” for new OTCQB companies. QBie™ Spotlight helps issuers that are new to the OTCQB connect with microcap industry professionals! Learn more about the QBie™ Spotlight HERE.

Disclaimer/Forward Looking Statements: 

This Website and its contents are not to be construed, under any circumstances, as an offer to sell or a solicitation to buy or effect transactions in any securities. No investment advice is provided or should be construed to be provided herein. This Website and its owners, employees and affiliates are not, nor do any of them claim to be, registered broker-dealers or registered investment advisors. This Website may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Such forward-looking statements of or concerning the companies mentioned herein are subject to numerous uncertainties and risk factors, including uncertainties and risk factors that may not be set forth herein, which could cause actual results to differ materially from those stated herein. Accordingly, user of this Website are cautioned not to place undue reliance on such forward-looking statements. This Website undertakes no obligation to update any forward-looking statements that may be contained herein.